Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5.
In order to determine the importance of the O75 O antigen versus the K5 capsular antigen and the bimodal distribution of lipopolysaccharides (LPSs) in protection from complement-mediated lysis, mutants were made by insertion of a cat or an aphA gene in or in place of genes necessary for the synthesis of LPS and/or the K antigen of an O75(+) K5(+) uropathogenic Escherichia coli strain, GR-12. Mutations were made in the following genes: the rfbD gene (required for the synthesis of TDP-rhamnose), the rfbKM genes (necessary for the synthesis of GDP-mannose), the rol gene (regulating O-antigen length), the kfiC gene (encoding a putative glycosyltransferase), and the kfiC-rfbD genes. The resulting phenotypes were rough (O75(-)), core plus one partial O-antigen subunit, random distribution of O-antigen chain lengths, acapsular (K5(-)), and O75(-) K5(-), respectively. All five mutants and GR-12 were analyzed for survival in 80% serum. The GR-12 parent was resistant, exhibiting a 500% increase in numbers. The rol, rfbKM, rfbD, and kfiC-rfbD mutants were sensitive, experiencing 99%, 99.9%, 99.9%, and at least 99.999% killing, respectively, in the first hour. The kfiC mutant, however, increased in numbers in the first hour but experienced delayed sensitivity, decreasing in viability by 80% in the third hour. Single mutants were complemented with the wild-type gene in trans, showing restoration of the wild-type phenotype and serum resistance. Therefore, the O75 antigen is more important for survival in serum than the K5 antigen, and regulation of the O75 O-antigen chain length is crucial for protection of the bacteria from complement-mediated lysis.
Burns
S M
SM
Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA. sb691010@bcm.tmc.edu
Hull
S I
SI
D016667:Bacterial Capsules; D003165:Complement System Proteins / Q000276:immunology*; D004926:Escherichia coli / Q000235:genetics / Q000276:immunology*; D005816:Genetic Complementation Test; D006801:Humans; D008070:Lipopolysaccharides / Q000276:immunology*; D009154:Mutation; D019081:O Antigens / Q000276:immunology*; D010641:Phenotype; D011135:Polysaccharides, Bacterial / Q000235:genetics / Q000276:immunology*
D008070:Lipopolysaccharides; D019081:O Antigens; D011135:Polysaccharides, Bacterial; C050673:capsular polysaccharide K5; D003165:Complement System Proteins